Memorial Sloan Kettering and Molecular Templates partnered to research engineered toxin bodies (ETBs) to treat lymphoma and Kettering granted MT an exclusive license to IP generated from the research

Memorial Sloan Kettering Cancer Center

U.S. / Non-Profit or Major Disease Foundation

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Molecular Templates Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced